In the Press
Advaita Bioinformatics displaces major competitor in Australia and New Zealand
Advaita announces new distribution partnership with Millennium Science.ANN ARBOR, Michigan, April 23, 2019 –Advaita Bioinformatics, provider of the industry-leading gene expression and genomic variation analysis platform, announces a new partnership with Millennium Science for distribution of Advaita’s software to research institutions and pharma companies across Australia and New Zealand. The partnership is effective immediately and Millennium Science is replacing Qiagen’s Ingenuity products with iPathwayGuide™ and iVariantGuide products for all pathway and variant analysis.According to Millennium Science’s Business Development Manager, James Miller: “We reviewed the currently available products for pathway and variant analysis and we have declared iPathwayGuide™ and iVariantGuide the [...]
Advaita Bioinformatics Awarded Competitive Grant from the National Science Foundation
Plymouth, MI (August 13, 2017 )– Advaita Bioinformatics, one of the most innovative companies in the field of Genomics, has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant of $225,000 to conduct research and development (R&D) work on a new method of predicting clinically-relevant disease subtypes. Groundbreaking results obtained using real cancer patient data show that Advaita’s proprietary technology is able to distinguish between more and less aggressive types of cancer without any prior knowledge.Treating specific subtypes of disease can be very effective but depends crucially on the correct disease subtyping. Even for targeted drugs [...]
Advaita Launches One Of The First HIPAA-Compliant Genetic Interpretation Analysis Tool For Clinics
Plymouth, MI (June 13, 2017) - Genetic analysis and variant interpretation has come a long way. However, to make this science a viable option for patient care, it is required for companies to make this data HIPAA compliant, easily readable, understandable and accessible to healthcare professionals. Advaita Bioinformatics has become of the first companies to make their cloud-based product available in a HIPAA compliant environment. Its iVariantGuide is the next-generation software suite for genetic variant analysis that brings precision and personalized medicine one step closer to everyday clinical practice. Advaita announced today that the newly-released iVariantGuide now meets all of [...]
NCI selects Advaita Bio for NCI site-wide Next-gen Bioinformatics solution provider
Advaita Bio's iPathwayGuide™ was chosen after a lengthy evaluation to be a side-wide solutions provider for the analysis of mRNA and protein expression data for all researchers attached to the National Cancer Institute (NCI). Its ease of use, advance analytic capabilities, and price point were all factors in its selection. Andrew Olson, Vice President of Business Development remarked, “It is a great honor to be recognized by NCI, one of the Nation's premier cancer research organizations, as having a world-class solution for the analysis of these high-throughput data.” He continued, “We look forward to working with NCI to expand iPathwayGuide™’s [...]
